109 related articles for article (PubMed ID: 38763418)
1. Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma.
Fernández-Miranda I; Pedrosa L; González-Rincón J; Espinet B; de la Cruz Vicente F; Climent F; Gómez S; Royuela A; Camacho FI; Martín-Acosta P; Yanguas-Casás N; Domínguez M; Méndez M; Colomo L; Salar A; Horcajo B; Navarro M; García-Cosío M; Piris-Villaespesa M; Llanos M; García JF; Sequero S; Mercadal S; García-Hernández S; Navarro B; Mollejo M; Provencio M; Sánchez-Beato M
Mod Pathol; 2024 May; 37(7):100516. PubMed ID: 38763418
[TBL] [Abstract][Full Text] [Related]
2. Early histological transformation of follicular lymphoma to diffuse large B-cell lymphoma indicating adverse survival: A population-based analysis and validation.
Li ZH; Zhang MY; Federico M; Civallero M; Manni M; Alonso-Alvarez S; Hou J; Huang HH
Cancer; 2024 May; ():. PubMed ID: 38809573
[TBL] [Abstract][Full Text] [Related]
3. PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation.
Beck Enemark M; Monrad I; Madsen C; Lystlund Lauridsen K; Honoré B; Plesner TL; Hamilton-Dutoit SJ; d'Amore F; Ludvigsen M
Onco Targets Ther; 2021; 14():481-489. PubMed ID: 33500624
[TBL] [Abstract][Full Text] [Related]
4. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.
Montoto S; Davies AJ; Matthews J; Calaminici M; Norton AJ; Amess J; Vinnicombe S; Waters R; Rohatiner AZ; Lister TA
J Clin Oncol; 2007 Jun; 25(17):2426-33. PubMed ID: 17485708
[TBL] [Abstract][Full Text] [Related]
5. Histologic transformation of follicular lymphoma: pathologists' viewpoint.
Maeshima AM
J Clin Exp Hematop; 2023; 63(1):12-18. PubMed ID: 36990772
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of the transformation of follicular lymphoma to diffuse large B-cell lymphoma in the rituximab era: A population-based study.
Zheng W; Liu M; Guan L; Wang S
Cancer Med; 2024 Apr; 13(8):e7120. PubMed ID: 38629251
[TBL] [Abstract][Full Text] [Related]
7. Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma.
Qu Z; Zhang T; Gao F; Gong W; Cui Y; Qiu L; Qian Z; Zhou S; Meng B; Ren X; Li L; Wang X; Zhang H
Biomed Res Int; 2022; 2022():4379556. PubMed ID: 35655476
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial.
Sarkozy C; Trneny M; Xerri L; Wickham N; Feugier P; Leppa S; Brice P; Soubeyran P; Gomes Da Silva M; Mounier C; Offner F; Dupuis J; Caballero D; Canioni D; Paula M; Delarue R; Zachee P; Seymour J; Salles G; Tilly H
J Clin Oncol; 2016 Aug; 34(22):2575-82. PubMed ID: 27298402
[TBL] [Abstract][Full Text] [Related]
9. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.
Huet S; Tesson B; Jais JP; Feldman AL; Magnano L; Thomas E; Traverse-Glehen A; Albaud B; Carrère M; Xerri L; Ansell SM; Baseggio L; Reyes C; Tarte K; Boyault S; Haioun C; Link BK; Feugier P; Lopez-Guillermo A; Tilly H; Brice P; Hayette S; Jardin F; Offner F; Sujobert P; Gentien D; Viari A; Campo E; Cerhan JR; Salles G
Lancet Oncol; 2018 Apr; 19(4):549-561. PubMed ID: 29475724
[TBL] [Abstract][Full Text] [Related]
10. Non-diffuse large B-cell lymphoma transformation from follicular lymphoma: a single-institution study of 19 cases.
Maeshima AM; Taniguchi H; Ida H; Hosoba R; Fujino T; Saito Y; Yuda S; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
Hum Pathol; 2020 Aug; 102():33-43. PubMed ID: 32540222
[TBL] [Abstract][Full Text] [Related]
11. Transformation Scoring System (TSS): A new assessment index for clinical transformation of follicular lymphoma.
Shichijo T; Maruyama D; Yamauchi N; Maeshima AM; Sugano M; Yuda S; Tajima K; Kurihara H; Shimada K; Suzuki T; Toyoda K; Makita S; Fukuhara S; Munakata W; Suzuki T; Kobayashi Y; Taniguchi H; Minami Y; Izutsu K; Tobinai K
Cancer Med; 2020 Dec; 9(23):8864-8874. PubMed ID: 33022120
[TBL] [Abstract][Full Text] [Related]
12. The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.
Giné E; Montoto S; Bosch F; Arenillas L; Mercadal S; Villamor N; Martínez A; Colomo L; Campo E; Montserrat E; López-Guillermo A
Ann Oncol; 2006 Oct; 17(10):1539-45. PubMed ID: 16940035
[TBL] [Abstract][Full Text] [Related]
13. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
González-Rincón J; Méndez M; Gómez S; García JF; Martín P; Bellas C; Pedrosa L; Rodríguez-Pinilla SM; Camacho FI; Quero C; Pérez-Callejo D; Rueda A; Llanos M; Gómez-Codina J; Piris MA; Montes-Moreno S; Bárcena C; Rodríguez-Abreu D; Menárguez J; de la Cruz-Merino L; Monsalvo S; Parejo C; Royuela A; Kwee I; Cascione L; Arribas A; Bertoni F; Mollejo M; Provencio M; Sánchez-Beato M
PLoS One; 2019; 14(2):e0212813. PubMed ID: 30802265
[TBL] [Abstract][Full Text] [Related]
14. An Externally Validated Nomogram for Predicting the Overall Survival of Patients With Diffuse Large B-Cell Lymphoma Based on Clinical Characteristics and Systemic Inflammatory Markers.
Liu Y; Sheng L; Hua H; Zhou J; Zhao Y; Wang B
Technol Cancer Res Treat; 2023; 22():15330338231180785. PubMed ID: 37551117
[No Abstract] [Full Text] [Related]
15. High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation.
Carreras J; Lopez-Guillermo A; Kikuti YY; Itoh J; Masashi M; Ikoma H; Tomita S; Hiraiwa S; Hamoudi R; Rosenwald A; Leich E; Martinez A; Roncador G; Villamor N; Colomo L; Perez P; Tsuji NM; Campo E; Nakamura N
J Clin Exp Hematop; 2019; 59(1):1-16. PubMed ID: 30918139
[TBL] [Abstract][Full Text] [Related]
16. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
17. Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns.
Dreval K; Hilton LK; Cruz M; Shaalan H; Ben-Neriah S; Boyle M; Collinge B; Coyle KM; Duns G; Farinha P; Grande BM; Meissner B; Pararajalingam P; Rushton CK; Slack GW; Wong J; Mungall AJ; Marra MA; Connors JM; Steidl C; Scott DW; Morin RD
Blood; 2023 Aug; 142(6):561-573. PubMed ID: 37084389
[TBL] [Abstract][Full Text] [Related]
18. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Bischin AM; Dorer R; Aboulafia DM
Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
[TBL] [Abstract][Full Text] [Related]
19. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O
Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760
[TBL] [Abstract][Full Text] [Related]
20. [Clinical Features of Diffuse Large B-Cell Lymphoma Transformed from Follicular Lymphoma].
Zhang XL; Yu WJ; Zhu YN; Yang CM; Xiao F; Mai WY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1772-1778. PubMed ID: 36476902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
